Cardinal Health, Inc. $CAH Shares Acquired by Forsta AP Fonden

Forsta AP Fonden raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 27.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 130,300 shares of the company’s stock after buying an additional 28,200 shares during the quarter. Forsta AP Fonden owned about 0.05% of Cardinal Health worth $21,890,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. Atlantic Edge Private Wealth Management LLC boosted its holdings in Cardinal Health by 75.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health in the 1st quarter worth about $26,000. NewSquare Capital LLC boosted its holdings in shares of Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after buying an additional 107 shares during the period. GW&K Investment Management LLC grew its position in shares of Cardinal Health by 113.4% during the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after buying an additional 144 shares during the last quarter. Finally, Harbor Asset Planning Inc. bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $49,000. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CAH shares. Argus raised their target price on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. UBS Group raised their target price on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Citigroup boosted their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Finally, Robert W. Baird set a $232.00 price target on shares of Cardinal Health in a research report on Friday, October 31st. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $205.00.

Cardinal Health Stock Performance

NYSE:CAH opened at $204.14 on Thursday. The stock has a market cap of $48.50 billion, a price-to-earnings ratio of 31.65, a PEG ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $207.47. The business has a fifty day moving average of $163.33 and a 200-day moving average of $158.16.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Insider Activity

In other news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 in the last quarter. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.